NEW YORK (GenomeWeb) – Microarray-based non-invasive prenatal testing firm CellScape has shut down.
According to its LinkedIn page, the company, which had been headquartered in Newark, Calif., ceased operations in September.
NEW YORK (GenomeWeb) – Sequenom is looking to its deal with Quest Diagnostics and a new noninvasive prenatal test, VisibiliT, which it will launch in Europe for trisomies 21 and 18, to help drive new revenue growth, company officials said this week.
NEW YORK (GenomeWeb) — Affymetrix and Ariosa Diagnostics today announced that they have signed a multi-year agreement under which Affymetrix will supply arrays and instruments for use in Ariosa's Harmony non-invasive prenatal test.
As it continues to expand its presence in the non-invasive prenatal testing market, Natera has been developing its technology for the cancer diagnostics space and is poised to make announcements in that area "very soon."
NEW YORK (GenomeWeb) – A US Patent and Trademark Office board has declared that certain claims on a patent held by Sequenom are unpatentable, while it upheld other claims on the patent, US Patent No. 6,258,540.